Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. Trial of Psilocybin Versus Escitalopram for Depression , 384 New England J.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. 16, 2016), available at [link]. Id ; 21 CFR 312.1-10; 10; 312.80-88; 88; 312.300 et seq.

Law 105

Law Therapy Clinical Trials Research and Development 105

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. Qualifying conditions for medical marijuana. percent) remains far higher than the world average (3.9

Legalization 52

Legalization Access Medicine Clinical Trials 52

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. Conditioned place preference.

Therapy 98

Therapy CBD Research and Development Treatment 98

The Cannigma

MAY 13, 2022

Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. 12 Pinene had the ability to meditate chemical responses to inflammation in rodent trials.

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. Market Segmentation. Market Dynamics.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

DECEMBER 14, 2019

Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. Writes Investing News.com.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

CannaMD

NOVEMBER 6, 2019

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4 More Information.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

SpeedWeed

AUGUST 4, 2021

I attended my first medical cannabis symposium in Sydney in 2016. This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. . They presented case studies about patients who have had incredible success from their cannabis treatments.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

APRIL 10, 2019

In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. There is evidence that CBD may be beneficial in the treatment of intractable epilepsy, and over 80 children have already been supplied with CBD products in the UK on the basis of a specialist doctor’s prescription.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition. This system shows up in several studies.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. About Silver Spike Capital.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JUNE 11, 2019

The accident also reactivated a pre-existing psychological condition which manifested as a chronic pain syndrome, and a pre-existing depressive disorder which was in partial remission at the time of trial. Compensation is not payable for treatments that “simply improve the plaintiff’s enjoyment of life” 32.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

FloridaMarijuana.net

AUGUST 13, 2018

Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. There are a variety of treatment options to help patients cope with and heal from anxiety disorders.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Project CBD

OCTOBER 26, 2023

As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer. They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM).

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

CannaMD

MARCH 8, 2021

Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Revising a provision relating to the potency of tetrahydrocannabinol in edibles dispensed by a medical marijuana treatment center [p.1, 2, line 32]. 2, line 38]. 1, line 12]. 2, line 26]. 2, line 29].

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Market Segmentation.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

SEPTEMBER 1, 2019

By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. In late 2016, Faenza was working with a team to identify potential Australian sites and scan the international market for the best production methods.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Legalisation occurred in Australia in 2016. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. An estimated 4 million to 6 million Americans are on disability because of TBI.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. An estimated 4 million to 6 million Americans are on disability because of TBI.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

MARCH 21, 2019

If you reside in any of the following 15 states, there are laws stating certain conditions must be met in order to legally obtain CBD. Georgia only allows patients diagnosed with cancer, ALS, seizures, and other serious medical conditions to legally possess CBD. You can find the list of medical conditions here.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 7/2016 (498-501). 1Alexandra L.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JUNE 30, 2019

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. The panel also took up a bill sponsored by Rep. Medical / Health.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40